Medicine and Dentistry
Adverse Event
14%
Bronchoscopy
9%
Chronic Obstructive Pulmonary Disease
51%
Computer Assisted Tomography
10%
Denervation
14%
Dyspnea
9%
Emphysema
100%
Endobronchial Valve
67%
Epileptic Absence
7%
Epithelial Cell
5%
Exercise
13%
Forced Expiratory Volume
14%
Lung Function
10%
Lung Transplantation
9%
Lung Volume
80%
Patient Selection
8%
Pneumothorax
10%
Pulmonary Rehabilitation
5%
Quality of Life
20%
Randomized Controlled Trial
9%
Residual Volume
19%
St. George Respiratory Questionnaire
18%
Symptom
5%
Keyphrases
6-minute Walk Distance (6MWD)
7%
Bronchoscopic Lung Volume Reduction
33%
Chronic Obstructive Pulmonary Disease Patient
5%
Collateral Ventilation
10%
COPD Patients
7%
Emphysema
32%
Endobronchial Coils
8%
Endobronchial Valve Therapy
5%
Endobronchial Valve Treatment
23%
Endobronchial Valves
22%
Exercise Capacity
6%
Forced Expiratory Volume in 1 Second (FEV1)
16%
Homogeneous Emphysema
6%
Hyperinflation
9%
Lobar
6%
Lung Volume Reduction
9%
Lung Volume Reduction Coils
8%
Minimal Clinically Important Difference
6%
One-way Valve
5%
Patient Selection
7%
Pneumothorax
5%
Pulmonary Function
6%
Quality of Life
10%
Reduction Method
8%
Residual Volume
16%
Severe Chronic Obstructive Pulmonary Disease
5%
Severe COPD
8%
Severe Emphysema
29%
St. George's Respiratory Questionnaire
9%
Treatment Options
7%
Valve Treatment
5%
Volume Reduction
5%
Zephyr
5%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
18%
Asthma
5%
Chronic Obstructive Lung Disease
41%
Cigarette Smoke
10%
Clinical Trial
7%
Combination Therapy
5%
Disease
6%
Dyspnea
8%
Emphysema
67%
Pneumothorax
8%
Randomized Controlled Trial
8%